OnCore Login

Return to Trial Database

HCRN-GYN98-1

A Phase II Trial of Ifosfamide and Oral Etoposide For Refractory Ovarian Cancer

Status

Study Completed

Cancer Type(s)

Ovarian

Study Contact

Publications

A Phase II Study of Ifosfamide plus Etoposide in Previously treated Ovarian Cancer
  • M Shaheen, JW McClean, LH Einhorn
Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer
  • M1 Shaheen, MJ Stender, JW McClean, KY Look, LH Einhorn

Trial Locations

All sites in which the trial HCRN-GYN98-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278